An open-label, DDI study to investigate the effects of amlitelimab on the PK of selected cytochrome P450 substrates

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513495-17-00

Acronym

INT18404

Enrollment

Registered

2024-11-01

Start date

2024-11-20

Completion date

Unknown

Last updated

2025-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatitis atopic

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Bulgaria, Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026